US2017022232A1PendingUtilityA1

Method for in-situ formation of metathesis catalysts

60
Assignee: SCHRODI YANNPriority: Mar 24, 2010Filed: Apr 20, 2016Published: Jan 26, 2017
Est. expiryMar 24, 2030(~3.7 yrs left)· nominal 20-yr term from priority
Inventors:Yann Schrodi
B01J 2231/543C07C 67/333B01J 31/2295C07D 211/94C07C 2101/10C07F 15/0046C07D 223/04B01J 31/2404B01J 2531/821C07D 207/46B01J 2531/825C07C 2601/10B01J 31/2265C07C 6/04C07D 207/48B01J 31/122C07D 211/96
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Synthetic methods for the in-situ formation of olefin metathesis catalysts are disclosed, as well as the use of such catalysts in metathesis reactions of olefins and olefin compounds. In one aspect, a method is provided for synthesizing an organometallic compound of the formula comprising contacting a precursor compound of the formula (X 1 X 2 ML j L 1 k L 3 m ) i with an acetylenic compound comprising a chelating moiety, optionally, in the presence of a neutral electron donor, wherein M is a Group 8 transition metal, L, L 1 , L 2 , and L 3 are neutral electron donors, X 1 and X 2 are anionic ligands, j is 1, 2, or 3; k is zero, 1, or 2; m is zero or 1; n is 1 or 2; and i is an integer; with the proviso that k is zero when the precursor compound is contacted with the acetylenic compound in the presence of the neutral electron donor, and R 1 and R 2 are independently selected from hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups, wherein R 1 and R 2 are linked and together form one or more cyclic groups, R 2 and L 2 are linked and together form one or more cyclic groups, and any other two or more of X 1 , X 2 , L 1 , L 2 , L 3 , R 1 , and R 2 can be taken together to form one or more cyclic groups. The invention has utility in the fields of catalysis, organic synthesis, polymer chemistry, and industrial and fine chemicals chemistry.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A compound of the formula 
       
         
           
           
               
               
           
         
       
       wherein
 M is a Group 8 transition metal; 
 L 1 , L 2 , and L 3  are neutral electron donor ligands; 
 m is zero or 1; and n is 1 or 2; 
 X 1  and X 2  are anionic ligands; and 
 R 1  and R 2  are independently selected from hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups, wherein R 1  and R 2  are linked and together form one or more cyclic groups, R 2  and L 2  are linked and together form one or more cyclic groups, and any other two or more of X 1 , X 2 , L 1 , L 2 , L 3 , R 1 , and R 2  can be taken together to form one or more cyclic groups. 
 
     
     
         2 . The compound of  claim 1 , wherein M is Ru or Os. 
     
     
         3 . The compound of  claim 1 , wherein L 1 , L 2 , and L 3  are independently selected from phosphine, sulfonated phosphine, phosphite, phosphinite, phosphonite, arsine, stibine, ether, amine, amide, imine, sulfoxide, carboxyl, nitrosyl, pyridine, substituted pyridine, imidazole, substituted imidazole, pyrazine, thioether, and thiocarbonyl. 
     
     
         4 . The compound of  claim 3 , wherein the phosphine is of the formula PR a R b R c , wherein R a , R b , and R c  are each independently selected from aryl, substituted aryl, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, heterocycles, and substituted heterocycles. 
     
     
         5 . The compound of  claim 1 , wherein X 1  and X 2  are independently selected from hydrogen, halide, C 1 -C 20  alkyl, C 5 -C 20  aryl, C 1 -C 20  alkoxy, C 5 -C 20  aryloxy, C 2 -C 20  alkoxycarbonyl, C 6 -C 20  aryloxycarbonyl, C 2 -C 20  acyl, C 2 -C 20  acyloxy, C 1 -C 20  alkylsulfonato, C 5 -C 20  arylsulfonato, C 1 -C 20  alkylsulfanyl, C 5 -C 20  arylsulfanyl, C 1 -C 20  alkylsulfinyl, or C 5 -C 20  arylsulfinyl, any of which, with the exception of hydrogen and halide, are optionally further substituted with one or more groups selected from halide, C 1 -C 6  alkyl, C 1 -C 6  alkoxy, and C 5 -C 20  aryl. 
     
     
         6 . A compound of the formula 
       
         
           
           
               
               
           
         
       
       wherein
 M is a Group 8 transition metal; 
 L 1 , L 2 , and L 3  are neutral electron donor ligands; 
 m is zero or 1; and n is 1 or 2; 
 X 1  and X 2  are anionic ligands; and 
 R 1  and R 2  are independently selected from, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups, wherein R 1  and R 2  are linked and together form one or more cyclic groups, R 2  and L 2  are linked and together form one or more cyclic groups, and any other two or more of X 1 , X 2 , L 1 , L 2 , L 3 , R 1 , and R 2  can be taken together to form one or more cyclic groups; 
 wherein said compound is synthesized according to a method comprising contacting a precursor compound of the formula (X 1 X 2 ML j L 1   k L 3   m ) i  with an acetylenic compound comprising a chelating moiety, optionally, in the presence of a neutral electron donor L 1 ; wherein 
 M is a Group 8 transition metal; 
 L, L 1 , L 2 , and L 3  are neutral electron donors; 
 j is 1, 2, or 3; k is zero, 1, or 2; m is zero or 1; n is 1 or 2; and i is an integer; with the proviso that k is zero when the precursor compound is contacted with the acetylenic compound in the presence of the neutral electron donor L 1 ; 
 X 1  and X 2  are anionic ligands; and 
 R 1  and R 2  are independently selected from hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups, wherein R 1  and R 2  are linked and together form one or more cyclic groups, R 2  and L 2  are linked and together form one or more cyclic groups, and any other two or more of X 1 , X 2 , L 1 , L 2 , L 3 , R 1 , and R 2  can be taken together to form one or more cyclic groups. 
 
     
     
         7 . The compound of  claim 1 , wherein the compound is of the formula 
       
         
           
           
               
               
           
         
       
       wherein
 M, L 1 , L 3 , X 1 , X 2 , R 1 , n, and m are as defined in  claim 1 ; 
 R 5 , R 6 , R 7 , and R 8  are each independently selected from hydrogen, halogen, alkyl, alkenyl, alkynyl, aryl, heteroalkyl, heteroatom containing alkenyl, heteroalkenyl, heteroaryl, alkoxy, alkenyloxy, aryloxy, alkoxycarbonyl, carbonyl, alkylamino, alkylthio, aminosulfonyl, monoalkylaminosulfonyl, dialkylaminosulfonyl, alkylsulfonyl, nitrile, nitro, alkylsulfinyl, trihaloalkyl, perfluoroalkyl, carboxylic acid, ketone, aldehyde, nitrate, cyano, isocyanate, hydroxyl, ester, ether, amine, imine, amide, halogen-substituted amide, trifluoroamide, sulfide, disulfide, sulfonate, carbamate, silane, siloxane, phosphine, phosphate, borate, wherein R 1  and R 8  are linked and together form one or more cyclic groups, and any combination of R 1 , R 5 , R 6 , R 7 , and R 8  can be linked to form, one or more cyclic groups; 
 T is a heteroatom selected from N, O, S, and P; 
 Z is selected from hydrogen, alkyl, aryl, functionalized alkyl, and functionalized aryl, wherein the functional group(s) are independently selected from alkyl, aryl, alkoxy, aryloxy, halogen, carboxylic acid, ketone, aldehyde, nitrate, cyano, isocyanate, hydroxyl, ester, ether, amine, imine, amide, trifluoroamide, sulfide, disulfide, carbamate, silane, siloxane, phosphine, phosphate, or borate; and 
 n* is 1 or 2, such that n* is 1 for the divalent heteroatoms O or S, and n* is 2 for the trivalent heteroatoms N or P. 
 
     
     
         8 . The compound of  claim 7 , wherein R 1  and R 8  are linked to form a compound of the formula 
       
         
           
           
               
               
           
         
       
       wherein
 M is a Group 8 transition metal; 
 L 1  and L 3  are neutral electron donor ligands; 
 X 1  and X 2  are anionic ligands; 
 R 1  is selected from hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups; 
 n is 1 or 2 and m is zero or 1; 
 R 5 , R 6 , R 7 , R 8 , T, Z, and n* are as defined in  claim 7 ; and 
 R 10  is selected from hydrogen, halogen, alkyl, alkenyl, alkynyl, aryl, heteroalkyl, heteroatom containing alkenyl, heteroalkenyl, heteroaryl, alkoxy, alkenyloxy, aryloxy, alkoxycarbonyl, carbonyl, alkylamino, alkylthio, aminosulfonyl, monoalkylaminosulfonyl, dialkylaminosulfonyl, alkylsulfonyl, nitrile, nitro, alkylsulfinyl, trihaloalkyl, perfluoroalkyl, carboxylic acid, ketone, aldehyde, nitrate, cyano, isocyanate, hydroxyl, ester, ether, amine, inline, amide, halogen-substituted amide, trifluoroamide, sulfide, disulfide, sulfonate, carbamate, silane, siloxane, phosphine, phosphate, or borate, and wherein when R 10  is aryl or heteroaryl, R 10  may be substituted with any combination of R 5 , R 6 , R 7 , and R 8 , and further wherein R 10  can be linked with any of R 5 , R 6 , and R 7  to form one or more cyclic groups. 
 
     
     
         9 . A method of performing an olefin metathesis reaction, comprising contacting the compound of  claim 1  with an olefin. 
     
     
         10 . The method of  claim 9 , wherein M of the compound is Ru or Os. 
     
     
         11 . The method of  claim 10 , wherein L 1 , L 2 , and L 3  of the compound are independently selected from phosphine, sulfonated phosphine, phosphite, phosphinite, phosphonite, arsine, stibine, ether, amine, amide, imine, sulfoxide, carboxyl, nitrosyl, pyridine, substituted pyridine, imidazole, substituted imidazole, pyrazine, thioether, and thiocarbonyl. 
     
     
         12 . The method of  claim 9 , wherein X 1  and X 2  of the compound are independently selected from hydrogen, halide, C 1 -C 20  alkyl, C 5 -C 20  aryl, C 1 -C 20  alkoxy, C 5 -C 20  aryloxy, C 2 -C 20  alkoxycarbonyl, C 6 -C 20  aryloxycarbonyl, C 2 -C 20  acyl, C 2 -C 20  acyloxy, C 1 -C 20  alkylsulfonato, C 5 -C 20  arylsulfonato, C 1 -C 20  alkylsulfanyl, C 5 -C 20  arylsulfanyl, C 1 -C 20  alkylsulfinyl, or C 5 -C 20  arylsulfinyl, any of which, with the exception of hydrogen and halide, are optionally further substituted with one or more groups selected from halide, C 1 -C 6  alkyl, C 1 -C 6  alkoxy, and C 5 -C 20  aryl. 
     
     
         13 . The method of  claim 9  further comprising, prior to the contacting step, the step of forming the compound in situ. 
     
     
         14 . The method of  claim 9 , wherein the compound is of the formula 
       
         
           
           
               
               
           
         
       
       wherein
 R 5 , R 6 , R 7 , and R 8  are each independently selected from hydrogen, halogen, alkyl, alkenyl, alkynyl, aryl, heteroalkyl, heteroatom containing alkenyl, heteroalkenyl, heteroaryl, alkoxy, alkenyloxy, aryloxy, alkoxycarbonyl, carbonyl, alkylamino, alkylthio, aminosulfonyl, monoalkylaminosulfonyl, dialkylaminosulfonyl, alkylsulfonyl, nitrile, nitro, alkylsulfinyl, trihaloalkyl, perfluoroalkyl, carboxylic acid, ketone, aldehyde, nitrate, cyano, isocyanate, hydroxyl, ester, ether, amine, imine, amide, halogen-substituted amide, trifluoroamide, sulfide, disulfide, sulfonate, carbamate, silane, siloxane, phosphine, phosphate, borate, wherein R 1  and R 8  are linked and together form one or more cyclic groups, and any combination of R 1 , R 5 , R 6 , R 7 , and R 8  can be linked to form one or more cyclic groups; 
 T is a heteroatom selected from N, O, S, and P; 
 Z is selected from hydrogen, alkyl, aryl, functionalized alkyl, and functionalized aryl, wherein the functional group(s) are independently selected from alkyl, aryl, alkoxy, aryloxy, halogen, carboxylic acid, ketone, aldehyde, nitrate, cyano, isocyanate, hydroxyl, ester, ether, amine, imine, amide, trifluoroamide, sulfide, disulfide, carbamate, silane, siloxane, phosphine, phosphate, or borate; and 
 n* is 1 or 2, such that n* is 1 for the divalent heteroatoms O or S, and n* is 2 for the trivalent heteroatoms N or P. 
 
     
     
         15 . The method of  claim 11 , wherein the compound is of the formula 
       
         
           
           
               
               
           
         
       
       wherein
 R 5 , R 6 , R 7 , and R 8  are each independently selected from hydrogen, halogen, alkyl, alkenyl, alkynyl, aryl, heteroalkyl, heteroatom containing alkenyl, heteroalkenyl, heteroaryl, alkoxy, alkenyloxy, aryloxy, alkoxycarbonyl, carbonyl, alkylamino, alkylthio, aminosulfonyl, monoalkylaminosulfonyl, dialkylaminosulfonyl, alkylsulfonyl, nitrile, nitro, alkylsulfinyl, trihaloalkyl, perfluoroalkyl, carboxylic acid, ketone, aldehyde, nitrate, cyano, isocyanate, hydroxyl, ester, ether, amine, imine, amide, halogen-substituted amide, trifluoroamide, sulfide, disulfide, sulfonate, carbamate, silane, siloxane, phosphine, phosphate, borate, wherein R 1  and R 8  are linked and together form one or more cyclic groups, and any combination of R 1 , R 5 , R 6 , R 7 , and R 8  can be linked to form, one or more cyclic groups; 
 T is a heteroatom selected from N, O, S, and P; 
 Z is selected from hydrogen, alkyl, aryl, functionalized alkyl, and functionalized aryl, wherein the functional group(s) are independently selected from alkyl, aryl, alkoxy, aryloxy, halogen, carboxylic acid, ketone, aldehyde, nitrate, cyano, isocyanate, hydroxyl, ester, ether, amine, imine, amide, trifluoroamide, sulfide, disulfide, carbamate, silane, siloxane, phosphine, phosphate, or borate; and 
 n* is 1 or 2, such that n* is 1 for the divalent heteroatoms O or S, and n* is 2 for the trivalent heteroatoms N or P. 
 
     
     
         16 . The method of  claim 9 , wherein R 1  and R 8  of the compound are linked to form a compound of the formula 
       
         
           
           
               
               
           
         
       
       wherein
 M is a Group 8 transition metal; 
 L 1  and L 3  are neutral electron donor ligands; 
 X 1  and X 2  are anionic ligands; 
 R 1  is selected from hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups; 
 n is 1 or 2 and m is zero or 1; 
 R 5 , R 6 , R 7 , and R 8  are each independently selected from hydrogen, halogen, alkyl, alkenyl, alkynyl, and, heteroalkyl, heteroatom containing alkenyl, heteroalkenyl, heteroaryl, alkoxy, alkenyloxy, aryloxy, alkoxycarbonyl, carbonyl, alkylamino, alkylthio, aminosulfonyl, monoalkylaminosulfonyl, dialkylaminosulfonyl, alkylsulfonyl, nitrile, nitro, alkylsulfinyl, trihaloalkyl, perfluoroalkyl, carboxylic acid, ketone, aldehyde, nitrate, cyano, isocyanate, hydroxyl, ester, ether, amine, imine, amide, halogen-substituted amide, trifluoroamide, sulfide, disulfide, sulfonate, carbamate, silane, siloxane, phosphine, phosphate, borate, wherein R 1  and R 8  are linked and together form one or more cyclic groups, and any combination of R 1 , R 5 , R 6 , R 7 , and R 8  can be linked to form one or more cyclic groups; 
 T is a heteroatom selected from N, O, S, and P; 
 Z is selected from, hydrogen, alkyl, aryl, functionalized alkyl, and functionalized aryl, wherein the functional group(s) are independently selected from alkyl, aryl, alkoxy, aryloxy, halogen, carboxylic acid, ketone, aldehyde, nitrate, cyano, isocyanate, hydroxyl, ester, ether, amine, imine, amide, trifluoroamide, sulfide, disulfide, carbamate, silane, siloxane, phosphine, phosphate, or borate; 
 n* is 1 or 2, such that n* is 1 for the divalent heteroatoms O or S, and n* is 2 for the trivalent heteroatoms N or P; and 
 R 10  is selected from hydrogen, halogen, alkyl, alkenyl, alkynyl, aryl, heteroalkyl, heteroatom containing alkenyl, heteroalkenyl, heteroaryl, alkoxy, alkenyloxy, aryloxy, alkoxycarbonyl, carbonyl, alkylamino, alkylthio, aminosulfonyl, monoalkylaminosulfonyl, dialkylaminosulfonyl, alkylsulfonyl, nitrile, nitro, alkylsulfinyl, trihaloalkyl, perfluoroalkyl, carboxylic acid, ketone, aldehyde, nitrate, cyano, isocyanate, hydroxyl, ester, ether, amine, imine, amide, halogen-substituted amide, trifluoroamide, sulfide, disulfide, sulfonate, carbamate, silane, siloxane, phosphine, phosphate, or borate, and wherein when R 10  is aryl or heteroaryl, R 10  may be substituted with any combination of R 5 , R 6 , R 7 , and R 8 , and further wherein R 10  can be linked with any of R 5 , R 6 , and R 7  to form one or more cyclic groups. 
 
     
     
         17 . The method of  claim 11 , wherein R 1  and R 8  of the compound are linked to form a compound of the formula 
       
         
           
           
               
               
           
         
       
       wherein
 X 1  and X 2  are anionic ligands; 
 R 1  is selected from hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups; 
 n is 1 or 2 and m is zero or 1; 
 R 5 , R 6 , R 7 , and R 8  are each independently selected from hydrogen, halogen, alkyl, alkenyl, alkynyl, aryl, heteroalkyl, heteroatom containing alkenyl, heteroalkenyl, heteroaryl, alkoxy, alkenyloxy, aryloxy, alkoxycarbonyl, carbonyl, alkylamino, alkylthio, aminosulfonyl, monoalkylaminosulfonyl, dialkylaminosulfonyl, alkylsulfonyl, nitrile, nitro, alkylsulfinyl, trihaloalkyl, perfluoroalkyl, carboxylic acid, ketone, aldehyde, nitrate, cyano, isocyanate, hydroxyl, ester, ether, amine, imine, amide, halogen-substituted amide, trifluoroamide, sulfide, disulfide, sulfonate, carbamate, silane, siloxane, phosphine, phosphate, borate, wherein R 1  and R 8  are linked and together form one or more cyclic groups, and any combination of R 1 , R 5 , R 6 , R 7 , and R 8  can be linked to form one or more cyclic groups; 
 T is a heteroatom selected from N, O, S, and P; 
 Z is selected from hydrogen, alkyl, aryl, functionalized alkyl, and functionalized aryl, wherein the functional group(s) are independently selected from alkyl, aryl, alkoxy, aryloxy, halogen, carboxylic acid, ketone, aldehyde, nitrate, cyano, isocyanate, hydroxyl, ester, ether, amine, imine, amide, trifluoroamide, sulfide, disulfide, carbamate, silane, siloxane, phosphine, phosphate, or borate; 
 n* is 1 or 2, such that n* is 1 for the divalent heteroatoms O or S, and n* is 2 for the trivalent heteroatoms N or P; and 
 R 10  is selected from hydrogen, halogen, alkyl, alkenyl, alkynyl, aryl, heteroalkyl, heteroatom containing alkenyl, heteroalkenyl, heteroaryl, alkoxy, alkenyloxy, aryloxy, alkoxycarbonyl, carbonyl, alkylamino, alkylthio, aminosulfonyl, monoalkylaminosulfonyl, dialkylaminosulfonyl, alkylsulfonyl, nitrile, nitro, alkylsulfinyl, trihaloalkyl, perfluoroalkyl, carboxylic acid, ketone, aldehyde, nitrate, cyano, isocyanate, hydroxyl, ester, ether, amine, imine, amide, halogen-substituted amide, trifluoroamide, sulfide, disulfide, sulfonate, carbamate, silane, siloxane, phosphine, phosphate, or borate, and wherein when R 10  is aryl or heteroaryl, R 10  may be substituted with any combination of R 5 , R 6 , R 7 , and R 8 , and further wherein R 10  can be linked with any of R 5 , R 6 , and R 7  to form one or more cyclic groups.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.